Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment

Seminars in Hematology

Volumn 46, Issue 4, 2009, Pages 371-377

  Camaschella, Clara ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ABC TRANSPORTER; DEFEROXAMINE; GENE PRODUCT; GLUTAREDOXIN; GLUTAREDOXIN 5; HEME; HEPCIDIN; IRON CHELATING AGENT; MESSENGER RNA; MITOCHONDRIAL DNA; PROTEIN SLC25A38; PYRIDOXINE; SULFUR; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; APOPTOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARBOXY TERMINAL SEQUENCE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GENE IDENTIFICATION; GENETIC SCREENING; HEREDITARY SIDEROBLASTIC ANEMIA; HUMAN; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; LOW DRUG DOSE; MAINTENANCE THERAPY; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN DEFECT; THALASSEMIA; X CHROMOSOME LINKED DISORDER;

5-AMINOLEVULINATE SYNTHETASE; ANEMIA, SIDEROBLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; COMBINED MODALITY THERAPY; ERYTHROID CELLS; GENETIC PREDISPOSITION TO DISEASE; GLUTAREDOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON OVERLOAD; MEMBRANE PROTEINS; MITOCHONDRIA; MUTATION; PEDIGREE; PHENOTYPE; TREATMENT OUTCOME;

EID: 70349335786     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.07.001     Document Type: Article

References (56)

1. Fleming M.D. The genetics of inherited sideroblastic anemias. Semin Hematol 39 (2002) 270-281
2. Bottomley S.S. Congenital sideroblastic anemias. Curr Hematol Rep 5 (2006) 41-49
3. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
4. Levi S., Corsi B., Bosisio M., Invernizzi R., Volz A., Sanford D., et al. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276 (2001) 24437-24440
5. Cazzola M., Invernizzi R., Bergamaschi G., Levi S., Corsi B., Travaglino E., et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 101 (2003) 1996-2000
6. Andrews N.C. Forging a field: the golden age of iron biology. Blood 112 (2008) 219-230
7. Cotter P.D., Baumann M., and Bishop D.F. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A 89 (1992) 4028-4032
8. Hunter G.A., and Ferreira G.C. 5-Aminolevulinate synthase: catalysis of the first step of heme biosynthesis. Cell Mol Biol 55 (2009) 102-110
9. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2 (2006) 406-414
10. Bekri S., May A., Cotter P.D., Al-Sabah A.I., Guo X., Masters G.S., et al. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia. Blood 102 (2003) 698-704
11. Astner I., Schulze J.O., van den Heuvel J., Jahn D., Schubert W.D., and Heinz D.W. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J 24 (2005) 3166-3177
12. Cox T.C., Bottomley S.S., Wiley J.S., Bawden M.J., Matthews C.S., and May B.K. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase. N Engl J Med 330 (1994) 675-679
13. Cotter P.D., May A., Fitzsimons E.J., Houston T., Woodcock B.E., al-Sabah A.I., et al. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest 96 (1995) 2090-2096
14. May A., and Bishop D.F. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anemia. Hematologica 83 (1998) 56-70
15. Cotter P.D., May A., Li L., Al-Sabah A.I., Fitzsimons E.J., Cazzola M., et al. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. Blood 93 (1999) 1757-1769
16. Furuyama K., Fujita H., Nagai T., Yomogida K., Munakata H., Kondo M., et al. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene. Blood 90 (1997) 822-830
17. Furuyama K., and Sassa S. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. J Clin Invest 105 (2000) 757-764
18. Whatley S.D., Ducamp S., Gouya L., Grandchamp B., Beaumont C., Badminton M.N., et al. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83 (2008) 408-414
19. Cazzola M., May A., Bergamaschi G., Cerani P., Rosti V., and Bishop D.F. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood 96 (2000) 4363-4365
20. Busque L., Mio R., Mattioli J., Brais E., Blais N., Lalonde Y., et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 88 (1996) 59-65
21. Aivado M., Gattermann N., Rong A., Giagounidis A.A., Prall W.C., Czibere A., et al. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis 37 (2006) 40-45
22. Guernsey D.L., Jiang H., Campagna D.R., Ferguson M., Kellogg M.D., et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. SC. Nat Genet (2009) doi:10.1038/ng.359 . Epub ahead of print
23. Rouault T.A., and Tong W.H. Iron-sulfur cluster biogenesis and human disease. Trends Genet 24 (2008) 398-407
24. Allikmets R., Raskind W.H., Hutchinson A., Schueck N.D., Dean M., Koeller D.M., et al. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8 (1999) 743-749
25. Pondarre C., Antiochos B.B., Campagna D.R., Clarke S.L., Greer E.L., Deck K.M., et al. The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis. Hum Mol Genet 15 (2006) 953-964
26. Pondarre C., Campagna D.R., Antiochos B., Sikorski L., Mulhern H., and Fleming M.D. Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood 109 (2007) 3567-3569
27. Camaschella C., Campanella A., De Falco L., Boschetto L., Merlini R., Silvestri L., et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 110 (2007) 1353-1358
28. Camaschella C. Recent advances in the understanding of inherited sideroblastic anemia. Br J Hematol 143 (2008) 27-38
29. Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L., et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate heme synthesis. Nature 436 (2005) 1035-1039
30. Iolascon A., De Falco L., and Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Hematologica 94 (2009) 395-408
31. Lill R., and Muhlenhoff U. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Ann Rev Biochem 77 (2008) 669-700
32. Taketani S., Kakimoto K., Ueta H., Masaki R., and Furukawa T. Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood 101 (2003) 3274-3280
33. Cavadini P., Biasiotto G., Poli M., Levi S., Verardi R., Zanella I., et al. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 109 (2007) 3552-3559
34. Boultwood J., Pellagatti A., Nikpour M., Pushkaran B., Fidler C., Cattan H., et al. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS ONE 3 (2008) e1970
35. Chen J.J. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 109 (2007) 2693-2699
36. Martin F.M., Prchal J., Nieva J., Saven A., Andrey J., Bethel K., et al. Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anemia. Br J Hematol 143 (2008) 446-450
37. Corsi B., Cozzi A., Arosio P., Drysdale J., Santambrogio P., Campanella A., et al. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277 (2002) 22430-22437
38. Santambrogio P., Biasiotto G., Sanvito F., Olivieri S., Arosio P., and Levi S. Mitochondrial ferritin expression in adult mouse tissues. J Histochem Cytochem 55 (2007) 1129-1137
39. Sheftel A.D., Zhang A.S., Brown C., Shirihai O.S., and Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110 (2007) 125-132
40. Munakata H., Sun J.Y., Yoshida K., Nakatani T., Honda E., Hayakawa S., et al. Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J Biochem 136 (2004) 233-238
41. Napier I., Ponka P., and Richardson D.R. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105 (2005) 1867-1874
42. Nakajima O., Okano S., Harada H., Kusaka T., Gao X., Hosoya T., et al. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes. Genes Cells 11 (2006) 685-700
43. Meyron-Holtz E.G., Ghosh M.C., Iwai K., LaVaute T., Brazzolotto X., Berger U.V., et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23 (2004) 386-395
44. Ishikawa H., Kato M., Hori H., Ishimori K., Kirisako T., Tokunaga F., et al. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol Cell 19 (2005) 171-181
45. Origa R., Galanello R., Ganz T., Giagu N., Maccioni L., Faa G., et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Hematologica 92 (2007) 583-588
46. Gardenghi S., Marongiu M.F., Ramos P., Guy E., Breda L., Chadburn A., et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109 (2007) 5027-5035
47. De Franceschi L., Daraio F., Filippini A., Carturan S., Muchitsch E.M., Roetto A., et al. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. Hematologica 91 (2006) 1336-1342
48. Tanno T., Bhanu N.V., Oneal P.A., Goh S.H., Staker P., Lee Y.T., et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13 (2007) 1096-1101
49. Della Porta M.G., Malcovati L., Invernizzi R., Travaglino E., Pascutto C., Maffioli M., et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 20 (2006) 549-555
50. St Pierre T.G., Clark P.R., Chua-Anusorn W., Fleming A.J., Jeffrey G.P., Olynyk J.K., et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105 (2005) 855-861
51. Yaouanq J., Grosbois B., Jouanolle A.M., Goasguen J., and Leblay R. Hemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anemia. Lancet 349 (1997) 1475-1476
52. Kemna E.H., Tjalsma H., Podust V.N., and Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53 (2007) 620-628
53. Ganz T., Olbina G., Girelli D., Nemeth E., and Westerman M. Immunoassay for human serum hepcidin. Blood 112 (2008) 4292-4297
54. Angelucci E., Barosi G., Camaschella C., Cappellini M.D., Cazzola M., Galanello R., et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Hematologica 93 (2008) 741-752
55. Pullarkat V., Blanchard S., Tegtmeier B., Dagis A., Patane K., Ito J., et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42 (2008) 799-805
56. Jensen P.D., Heickendorff L., Pedersen B., Bendix-Hansen K., Jensen F.T., Christensen T., et al. The effect of iron chelation on hemopoiesis in MDS patients with transfusional iron overload. Br J Hematol 94 (1996) 288-299